{
  "id": 5026357,
  "title": "Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes",
  "url": "https://urgent.news/2026/09/02/sun-pharma-agrees-to-supply-at-mfn-pricing-to-u-s-medicaid-programmes-5026357",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-02T04:56:53.000Z",
  "source": {
    "name": "The Hindu - Sci-Tech",
    "slug": "the-hindu-sci-tech",
    "url": "https://www.thehindu.com/business/Industry/sun-pharma-agrees-to-supply-at-mfn-pricing-to-us-medicaid-programmes/article71416574.ece"
  },
  "original_language": "en",
  "account": null,
  "summary": "The U.S. is the company’s largest market for innovative medicines and a cornerstone of its long-term growth strategy, generating approximately 27% of the company’s global revenue.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Hindustan Times",
        "title": "India's largest drugmaker Sun Pharma inks deal with US govt to supply cheaper medicines to Americans",
        "url": "https://urgent.news/2026/09/02/indias-largest-drugmaker-sun-pharma-inks-deal-with-us-govt-to-supply",
        "published": "2026-09-02T03:51:51.000Z"
      },
      {
        "outlet": "The Hindu Health",
        "title": "Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes",
        "url": "https://urgent.news/2026/09/02/sun-pharma-agrees-to-supply-at-mfn-pricing-to-u-s-medicaid-programmes",
        "published": "2026-09-02T04:56:53.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}